Our mission is to heal and restore. We are dedicated to advancing treatments in wound healing, infection control, and cosmeceuticals, developing solutions that enhance recovery and improve quality of life. By integrating cutting-edge biomaterials, antimicrobial peptides (AMPs), and regenerative medicine, we create technologies that accelerate healing, combat multiresistant bacteria, and support skin health.

Severe wounds, including burn injuries and chronic wounds, represent a major global healthcare challenge. Burn injuries are the fourth most common trauma worldwide, with the best outcomes historically achieved using biological tissue dressings derived from human or porcine skin. Chronic wounds affect 1–2% of the population, consuming up to 4% of healthcare budgets globally. In cases of severe complications, the amputation rate reaches 57%, with only 50% survival three years post-amputation.

By combining innovation, research, and medical expertise, we develop next-generation solutions that not only promote faster healing but also prevent complications, reduce costs, and improve patient outcomes.